IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — PKTX

Balance Sheet

(in millions USD)
MetricQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.000.000.050.010.000.000.010.020.010.040.020.060.15----
Total Current Assets------0.010.000.000.010.020.010.040.020.060.150.090.25
Intangible Assets0.480.470.480.470.470.460.440.450.440.430.390.370.340.320.31
Total Non-current Assets*------0.470.470.460.440.450.440.430.390.370.340.320.31
Total Assets0.480.470.530.480.470.460.450.470.450.480.410.430.490.410.56
Accounts Payable0.230.150.150.090.060.070.010.010.050.110.040.01----0.00
Total Current Liabilities0.230.150.150.090.060.070.010.010.050.110.040.010.010.010.01
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities*0.230.150.150.090.060.070.010.010.050.110.040.010.010.010.01
Retained Earnings(48.50)(48.42)(48.33)(48.13)(48.04)(47.96)(47.75)(47.67)(47.56)(46.86)(46.49)(46.06)(45.13)(43.73)(43.33)
Total Stockholder Equity0.250.330.380.390.410.390.440.450.390.370.380.420.480.400.56

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Research & Development0.020.020.020.030.020.020.020.040.040.020.030.020.020.160.100.160.190.100.110.04
Selling, General & Admin0.010.020.010.010.020.020.010.010.010.020.040.030.010.030.060.060.040.030.210.04
Total Operating Expenses0.120.080.090.100.100.080.090.090.110.080.120.110.580.370.440.520.391.400.400.13
Net Income(0.12)(0.08)(0.09)(0.10)(0.10)(0.08)(0.09)(0.09)(0.11)(0.08)(0.12)(0.11)(1.46)(0.37)0.44(0.52)(0.39)(1.40)(0.40)(0.13)
Basic EPS--0.000.000.000.010.000.00(0.01)0.00(0.01)(0.01)------------------
Diluted EPS--0.000.000.000.010.000.00(0.01)0.00(0.01)(0.01)------------------

Cash Flow Statement

(in thousands USD)
MetricQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Operating Cash Flow0.56(3.91)(80.06)(51.97)(45.24)(39.12)(80.85)(57.84)(77.47)(69.90)(143.76)(84.86)(147.17)(157.55)(163.63)(336.31)(233.72)(156.96)(344.20)(155.01)
Capital Expenditures18.3415.358.0420.9810.6517.3925.789.7436.461.3619.5313.7457.4942.5726.415.5824.0020.3411.5735.07
Free Cash Flow*(17.78)(19.26)(88.10)(72.95)(55.89)(56.51)(106.64)(67.57)(113.92)(71.26)(163.29)(98.61)(204.66)(200.12)(190.05)(341.89)(257.73)(177.30)(355.77)(190.08)
Investing Cash Flow(20.05)(5.60)(4.81)(25.86)(5.14)(17.39)(25.78)(9.74)(24.52)(1.36)(19.53)(13.74)(57.49)(42.56)(26.41)(5.58)(24.00)(20.34)(11.57)(35.07)
Financing Cash Flow20.0010.0035.50132.0040.0060.00106.0050.00110.0065.00175.0080.00186.50225.00150.00343.20170.00238.00190.00247.00

* Derived from reported values